Your browser doesn't support javascript.
loading
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Harrington, Brittney S; He, Yaowu; Khan, Tashbib; Puttick, Simon; Conroy, Paul J; Kryza, Thomas; Cuda, Tahleesa; Sokolowski, Kamil A; Tse, Brian Wc; Robbins, Katherine K; Arachchige, Buddhika J; Stehbens, Samantha J; Pollock, Pamela M; Reed, Sarah; Weroha, S John; Haluska, Paul; Salomon, Carlos; Lourie, Rohan; Perrin, Lewis C; Law, Ruby H P; Whisstock, James C; Hooper, John D.
Afiliação
  • Harrington BS; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • He Y; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.
  • Khan T; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Puttick S; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.
  • Conroy PJ; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Kryza T; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.
  • Cuda T; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Australia.
  • Sokolowski KA; Commonwealth Scientific and Industrial Research Organisation, Probing Biosystems Future Science Platform, Herston, QLD 4029, Australia.
  • Tse BW; Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3800, Australia.
  • Robbins KK; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Arachchige BJ; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.
  • Stehbens SJ; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Pollock PM; Preclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Reed S; Preclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Weroha SJ; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
  • Haluska P; Centre for Clinical Research, University of Queensland, Herston, Qld 4029, Australia.
  • Salomon C; Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD 4102, Australia.
  • Lourie R; Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD 4102, Australia.
  • Perrin LC; Centre for Clinical Research, University of Queensland, Herston, Qld 4029, Australia.
  • Law RHP; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Whisstock JC; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
  • Hooper JD; Merck Research Laboratories, Rahway, NJ, USA.
Theranostics ; 10(5): 2095-2114, 2020.
Article em En | MEDLINE | ID: mdl-32104500
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Moléculas de Adesão Celular / Imunoconjugados / Ressonância de Plasmônio de Superfície / Proteínas de Membrana Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Moléculas de Adesão Celular / Imunoconjugados / Ressonância de Plasmônio de Superfície / Proteínas de Membrana Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália